Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.

Breast Cancer Res Treat · 2021 · PMC8558195 · PMID 34570302

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a borderline significant trendno p-value reported

We did observe what appears to be a borderline significant trend of density reduction with higher CYP2D6 activity scores among postmenopausal women who received tamoxifen only and for all women who also received chemotherapy.

also in 231 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.